Immunic, Inc. (IMUX): Shareholders' Equity
-$6.67M
As of 2025-12-31
$127.58M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.67M | n/m | 2026-02-26, Balance as of period end |
| 2024-12-31 | $18.43M | -36.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $28.93M | -74.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $113.68M | -10.6% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $127.11M | -19.9% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $158.78M | +172.1% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $58.36M | n/m | 2021-02-26, Balance as of period end |
| 2018-12-31 | -$25.74M | n/m | 2020-03-16, Balance as of period end |
| 2017-12-31 | $50.04M | -14.4% | 2019-03-04, Balance as of period end |
| 2016-12-31 | $58.45M | -29.0% | 2019-03-04, Balance as of period end |
| 2015-12-31 | $82.33M | -15.6% | 2018-03-13, Balance as of period end |
| 2014-12-31 | $97.56M | n/m | 2017-03-07, Balance as of period end |
| 2013-12-31 | -$44.66M | n/m | 2016-03-08, Balance as of period end |
| 2012-12-31 | -$7.63M | n/a | 2015-03-20, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Immunic, Inc. (IMUX) | 2025-12-31 | -$6.67M | n/m |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $16.92M | -68.9% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $16.13M | -37.4% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $2.76M | n/m |
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $20.32M | +5.6% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.76M | +84.5% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $18.59M | -51.6% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $18.22M | -53.5% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $18.56M | +152.9% |
Compare IMUX, RNTX, KPRX, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗